The European market has recently experienced a positive shift, with the pan-European STOXX Europe 600 Index climbing 1.40% amid optimism surrounding potential U.S. rate cuts and a rise in business activity across the eurozone. In this environment, identifying high-growth tech stocks involves viewing for companies that can capitalize on expanding business activity and demonstrate resilience amidst fluctuating consumer confidence and economic conditions.
Here’s a peek at a few of the choices from the screener.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Oryzon Genomics S.A. is a clinical stage biopharmaceutical company focapplyd on developing epigenetics-based therapeutics for cancer and CNS disorders, with a market cap of €213.55 million.
Operations: Oryzon Genomics S.A. generates revenue primarily from its biotechnology segment, amounting to €7.47 million. The company focapplys on developing therapeutics based on epigenetics for cancer and central nervous system disorders.
Oryzon Genomics is poised for significant growth with an expected revenue increase of 56% annually, outpacing the broader Spanish market’s 4.3%. This biotech firm is navigating toward profitability with anticipated earnings growth of 58.89% per year over the next three years, reflecting its robust pipeline and innovative R&D efforts. Recent advancements include FDA discussions for their Phase III trial of vafidemstat in Borderline Personality Disorder, highlighting Oryzon’s commitment to addressing unmet medical necessarys through epigenetic therapies. Despite current unprofitability and a volatile share price, these strategic shifts could position Oryzon favorably in a competitive biotech landscape.
BME:ORY Earnings and Revenue Growth as at Aug 2025
Simply Wall St Growth Rating: ★★★★☆☆
Overview: LINK Mobility Group Holding ASA, along with its subsidiaries, offers mobile and communication-platform-as-a-service solutions and has a market cap of NOK9.41 billion.
Operations: The company generates revenue primarily from its regional segments: Central Europe (NOK 1.68 billion), Western Europe (NOK 2.25 billion), Northern Europe (NOK 1.56 billion), and Global Messaging (NOK 1.43 billion).
LINK Mobility Group Holding ASA is navigating a challenging landscape with a notable 16.2% annual revenue growth, outpacing the Norwegian market’s 2.1% increase. Despite recent setbacks including a significant one-off loss of NOK 116.3 million and a net loss this quarter, the company’s aggressive M&A strategy and integration of SMSPortal’s technology revealcase its commitment to strengthening market position and enhancing operational efficiencies. With earnings expected to surge by 59.6% annually, LINK is strategically positioning itself for robust future growth through both organic avenues and strategic acquisitions, signaling potential in an evolving European tech scene.
OB:LINK Earnings and Revenue Growth as at Aug 2025
Simply Wall St Growth Rating: ★★★★★☆
Overview: Synektik Spólka Akcyjna offers products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland with a market capitalization of PLN 1.90 billion.
Operations: Synektik Spólka Akcyjna generates revenue primarily from its Diagnostic and IT Equipment segment, which accounts for PLN 57.92 million, alongside the Production of Radio Pharmaceuticals contributing PLN 4.67 million.
Synektik Spólka Akcyjna, amidst a robust European tech landscape, has demonstrated significant financial performance with third-quarter revenue soaring to PLN 154.24 million from PLN 123.98 million year-over-year, and net income increasing to PLN 23.71 million from PLN 16.74 million. This growth trajectory is underscored by an annual earnings forecast increase of 21.9%, positioning the company well above the Polish market’s average growth rate of 4.3%. Additionally, Synektik’s strategic focus on enhancing operational efficiencies and expanding its technological capabilities suggests a promising outview for sustaining its growth momentum in a competitive sector.
WSE:SNT Revenue and Expenses Breakdown as at Aug 2025
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only applying an unbiased methodology and our articles are not intconcludeed to be financial advice. It does not constitute a recommconcludeation to acquire or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focapplyd analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BME:ORY OB:LINK and WSE:SNT.
